Created at	Source	Raw Value	Validated value
July 21, 2022, 12:30 p.m.	usa	GMT and SCR of specific neutralizing antibody (virus or pseudovirus) against SARS-CoV-2;Incidence of adverse drug reactions (ADRs)	GMT and SCR of specific neutralizing antibody (virus or pseudovirus) against SARS-CoV-2;Incidence of adverse drug reactions (ADRs)